logo

For the Inventor, By the Inventor

Tsukuba, Japan

Masashi Yanagisawa

This inventor holds 18 USPTO granted patents and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: The University of Texas System, Takeda Chemical Industries, Inc., University of Tsukuba. Active years: 1991-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masashi Yanagisawa. Retrieved from https://idiyas.com/inventor/masashi-yanagisawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18

% Patents Active = 88.9


Average Co-Inventor Count = 2.1

ph-index = 6

Forward Citations = 99(Granted Patents)


Location History:

  • Ibaraki, JP (1993 - 1996)
  • Dallas, TX (US) (1997 - 2014)
  • Okazaki, JP (2001 - 2020)
  • Tsukuba, JP (1991 - 2023)

Company Filing History:

goldMedal8 out of 5,640 
 
The University of Texas System
 patents
silverMedal3 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents
bronzeMedal3 out of 196 
 
University of Tsukuba
 patents
4. 1 out of 1 
 
501 Takeda Chemical Industries, Ltd.
 patent
5. 1 out of 1,430 
 
Agency of Industrial Science and Technology
 patents
6. 1 out of 2,468 
 
Nsk Corporation
 patents
7. 1 out of 2,198 
 
Smithkline Beecham Corporation
 patents
8. 1 out of 8 
 
Takeda Chemical Ind., Ltd.
 patents
9. 3 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1991-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Sulfonamide Derivative
Pharmaceutically Acceptable Salt
Small-Molecule Agonists
Type-2 Orexin Receptor
Neuropeptide Receptor
Polynucleotides
Endothelin
Vasoconstrictor Peptide
Abrasive Tool
Screening Methods
Recombinant Enzyme
Human Endothelin-3
18 patents (USPTO):Explore Patents
1. 11673867 - Sulfonamide derivative or pharmaceutically acceptable acid-addition salt (2023-06-13),
2. 10537976 - Former rotary dresser and dressing method (2020-01-21),
3. 10377763 - Morphinan derivative and medical usage thereof (2019-08-13),
4. 10351522 - Sulfonamide derivative and pharmaceutically acceptable acid addition salt thereof (2019-07-16),
5. 8871794 - Small-molecule agonists for type-2 orexin receptor (2014-10-28),
6. 8258163 - Small-molecule agonists for type-2 orexin receptor (2012-09-04),
7. 6750026 - Screening methods using ligands of the neutropeptide receptor HFGAN72 (2004-06-15),
8. 6309854 - Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72 (2001-10-30),
9. 6200360 - Abrasive tool and the method of producing the same (2001-03-13),
10. 6166193 - Polynucleotides encoding MY1 receptor (2000-12-26),
11. 6001963 - Ligands of the neuropeptide receptor HFGAN72 (1999-12-14),
12. 5811263 - DNA encoding human endothelin-3, and use thereof (1998-09-22),
13. 5736376 - Recombinant endothelin converting enzyme-2 and its use in ECE inhibitor (1998-04-07),
14. 5688640 - Methods of screening of effectors of endothelin converting enzyme-1 (1997-11-18),
15. 5548061 - Human endothelin-3 precursor protein (1996-08-20),

Title: The Innovative Journey of Masashi Yanagisawa

Introduction: Masashi Yanagisawa, a distinguished inventor hailing from Tsukuba, Japan, has made significant contributions to the field of innovation with his groundbreaking work in various scientific domains.

Latest Patents: Yanagisawa's recent patents showcase his ongoing commitment to pushing the boundaries of knowledge and technology, with a focus on advancements in biotechnology and medical research.

Career Highlights: Throughout his illustrious career, Masashi Yanagisawa has garnered recognition for his pioneering research in neuroscience, genetics, and molecular biology. His work has led to the development of novel treatments for neurological disorders and has opened new avenues for understanding the complexities of the human brain.

Collaborations: Yanagisawa's collaborative efforts with leading research institutions, universities, and biotechnology companies have been instrumental in driving forward the frontiers of scientific discovery. His partnerships have resulted in groundbreaking innovations that have the potential to revolutionize the healthcare industry.

Conclusion: Masashi Yanagisawa's unwavering dedication to innovation and his relentless pursuit of scientific excellence continue to inspire the next generation of inventors and researchers. His remarkable contributions to the field of biotechnology and medical research have left an indelible mark on the world of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…